Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4665 - 4672 of 11533 results
FDA Finalizes Guidance on Biosimilar Interchangeability, Reiterates Case-by-Case Approach to Data Requirements
May 16, 2019| Blog| Viewpoint
New Law Gives Student-Athletes Mandatory Whistleblower Protections
May 16, 2019| Blog| Viewpoint
Under New Guidance: Patent Eligibility of Computerized Diagnostics at the PTAB
May 15, 2019| Blog| Viewpoint
DHS Temporarily Preserves and Extends Temporary Protected Status (TPS) for Nationals of Nepal and Honduras
May 15, 2019| Alert| Viewpoint
Blockchain in Energy: A Practical Path to Standardization
May 15, 2019| Blog| Viewpoint
Health Care & Cybersecurity: A Powerful Combination
May 14, 2019| Blog| Viewpoint
ML Strategies Health Care Preview: Congress's Summer Plans Filling Up Fast
May 13, 2019| Blog| Viewpoint
Monthly TCPA Digest – May 2019
May 13, 2019| Article| Viewpoint
News & Press Releases
Mintz Advises Aspen Aerogels on $98M Follow-on Offering
November 19, 2024
Mintz advised Aspen Aerogels, Inc. (NYSE: ASPN), a technology leader in sustainability and electrification solutions, on a registered follow-on offering of 4,887,500 shares of its common stock, which included 637,500 shares pursuant to the underwriters’ option to purchase additional shares of its common stock. The price to the public in the offering was $20.00 per share and the gross proceeds to Aspen from the offering were approximately $98 million, before deducting underwriting discounts and commissions and estimated offering expenses.
Mintz Advises Charlesbank Capital Partners on Strategic Investment with IMPLAN Group
November 18, 2024
Mintz advised Charlesbank Capital Partners (“Charlesbank”), a middle-market private equity firm with more than $22 billion in total assets, on a strategic investment with IMPLAN Group LLC (“IMPLAN”), a leading provider of economic impact data and analytical software.
Mintz Recovers Over $400M for Institutional Investor Clients in 2024
November 14, 2024
Mintz's Institutional Investor Class Action Recovery Practice has recovered $400 million for institutional investor clients in 2024 and expects projects for recoveries exceeding $500 million by year end.